ReviewFrontiers in artificial intelligence2026
Review of deep learning models for Alzheimer's disease detection: MRI-centric approaches and multimodal extensions.
Review in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gender bias in the diagnosis of Alzheimer's Disease.Research square · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Alzheimer's disease (AD) is a leading cause of dementia worldwide, and an early, reliable diagnosis is critical for timely intervention. Structural magnetic resonance imaging (MRI), coupled with deep learning (DL), has emerged as a promising non-invasive approach for automated diagnosis. This review evaluates DL models applied to MRI for AD detection, while also considering multimodal extensions (PET, fMRI, DTI, CSF, and cognitive data) that augment MRI-based pipelines. Methods: Following PRISMA guidelines, a comprehensive search of six databases (2010-June 2025) identified 70 peer-reviewed studies, with many of them integrating multimodals as well. Data on model architectures, datasets, pre-processing, validation protocols, and reported performance outcomes were extracted and synthesised. Results: Most studies have employed 2D or 3D convolutional neural networks; however, recent work has also explored ensembles, vision transformers, graph neural networks, and generative models. ADNI was the primary dataset, in addition to OASIS, AIBL, UK Biobank, and other cohorts that were also utilised. Binary classification tasks distinguishing clinically diagnosed Alzheimer's disease (AD) patients from cognitively normal (CN) controls consistently reported high performance (>90% accuracy, AUC ≥ 0.95). In contrast, more clinically challenging tasks, such as multiclass classification across disease stages (CN, MCI, AD) and prediction of MCI-to-AD conversion, yielded substantially lower accuracy (approximately 70-85%). Reported near-perfect results (>99%) were often confined to single-site datasets lacking external validation, raising concerns of overfitting and reproducibility. Discussion: Few studies have incorporated differential diagnosis of dementia, advanced harmonisation across scanners, or open-source pipelines. Promising advances include transfer learning, multimodal integration, harmonisation methods (such as ComBat, GANs, diffusion), and explainable AI techniques. Overall, DL shows strong potential for MRI-based AD detection, with multimodal inputs further improving performance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.